Related references
Note: Only part of the references are listed.Thrombopoietin receptor agonists: ten years later
Waleed Ghanima et al.
HAEMATOLOGICA (2019)
Immune Thrombocytopenia
Nichola Cooper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Mechanisms and therapeutic prospects of thrombopoietin receptor agonists
James Bussel et al.
SEMINARS IN HEMATOLOGY (2019)
Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia
Wojciech Jurczak et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia
Renchi Yang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study
Raymond S. M. Wong et al.
BLOOD (2017)
Is ITP a thrombophilic disorder?
Francesco Rodeghiero
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study
Mette Norgaard et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis
Indraraj Umesh Doobaree et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies
Wendy J. Langeberg et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials
Ferran Catala-Lopez et al.
MEDICINA CLINICA (2015)
A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia
James B. Bussel et al.
BLOOD (2014)
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
David J. Kuter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopenia
Johanna Haselboeck et al.
THROMBOSIS AND HAEMOSTASIS (2013)
A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia
Y. Tomiyama et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial
Yukari Shirasugi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database
Ameet Sarpatwari et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)
T. B. Gernsheimer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
James B. Bussel et al.
LANCET (2009)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
